|
|
Do Not Use Synovo’s Total Hip Resurfacing System Including Resurfacing Implants: FDA Safety Communication
Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to inform health care providers not to use the Total Hip System, including resurfacing implants, manufactured by Synovo Production, Inc. (Synovo) and to inform patients who may have received certain implants used in the Synovo Total Hip System after 2019 that the safety and effectiveness of these devices have not been established.
Questions?
If you have questions about this safety communication, contact the Division of Industry and Consumer Education (DICE).
|
|
|
|
